Announcing Drug Safety Navigator's Acquisition of Five Oaks Pharm

Drug Safety Navigator, LLC is pleased to announce the acquisition of specialized drug safety and pharmacovigilance provider, Five Oaks Pharm, LLC.

Announcing Drug Safety Navigator's Acquisition of Five Oaks Pharm
Durham, NC, January 15, 2015 --( Drug Safety Navigator, LLC (DSN) expands its drug safety and pharmacovigilance services with the recent acquisition of Five Oaks Pharm, LLC, a company founded by industry veteran, Molly James, BSN, RN. The new services will include adverse event case management and medical information support.

Drug Safety Navigator, LLC (DSN) Founder & President, Dr. Michael J. Klepper released the following statement: “We are so pleased to add Molly James and her company formerly Five Oaks Pharm to the Drug Safety Navigator family. While working with her on several projects, we recognized that joining forces as one company would benefit our clients and enhance our service offerings. Ms. James will join us as partner and serve as Vice-President of Global Safety Operations.”

“The opportunity to partner with a leading global safety expert such as Dr. Klepper and the others at Drug Safety Navigator made sense at many levels. I look forward to building a full service safety company with service quality as the driver along with patient safety,” Ms. James stated in a letter to her clients.

This is an expansion of Drug Safety Navigator, LLC current services. “DSN received frequent requests for case management options, but the technology was not user friendly and start-up costs were a barrier. Now we can provide state of the art cloud based safety services customized for our client base,” explains Deena Wegner, Vice-President of Business Operations & Co-Founder.

About Drug Safety Navigator, LLC:
Drug Safety Navigator, LLC (DSN) provides highly experienced global drug safety experts for Adverse Event Case Management, Medical Writing & Consulting, Benefit-Risk Assessments, & Safety Signal Detection for various pharmaceutical and biotech clients. DSN services are especially geared to help small- and mid-sized companies that have exciting new therapies, but are under-resourced. When it comes to patient safety, DSN helps clients navigate through the murky waters of ongoing risk assessment and pharmacovigilance. While US based, DSN has partners around the world to support global clients and their products. The DSN logo says it all: Patient Safety is our True North.

To learn more about Drug Safety Navigator, please visit the new company website at, follow us on Twitter @DrugSafetyNavig, or call 919-371-0610.

Media Inquires:
Deena Wegner
Vice President & Co-Founder
Drug Safety Navigator, LLC
Phone: 919-371-0610
Drug Safety Navigator, LLC
Deena Wegner